Some Perspectives on lmmunosuppressive
Drugs
ROBERT S. SCHWARTZ

Department of Medicine, Tufts University School of Medicine
Boston, Massachusetts

My coming here to Richmond
to discuss immunosuppressive
drugs is surely carrying coals to
Newcastle, because the Medical
College of Virginia has been a
leader in this field, particularly with
reference to transplantation of the
kidney. I don't know what I can
tell you that you already don't know
about immunosuppression; nevertheless, you might be interested in
learning of our own experience
with these drugs.
The four main classes of cytotoxic drugs of interest to the immunologist are the alkylating agents
such as nitrogen mustard and cyclophosphamide, purine antagonists
( 6-mercaptopurine and azathioprine), the pyrimidine antagonists
such as 5-fluorouracil, and finally
the extremely interesting and potentially versatile agent methotrexate, a folic acid analog. Our laboratory has chosen to focus its
attention on a single class of these
compounds, the purine antagonists,
in an attempt to find out as much
about their immunological properties as we can. I plan to discuss two
aspects of this work: 1) Some of
the effects of 6-mercaptopurine (6MP) in experimental animals, and
2) some of the effects of its analogue, azathioprine, in man.

Purine Antagonists
6-Mercaptopurine, a rather simple analogue of hypoxanthine, has
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very powerful effects on cellular
metabolism. Azathioprine was synthesized with the hope that it would
have a higher therapeutic index
than the parent compound. Its imidazol ring was attached to the sulfur atom in the expectation that
this would slow down the metabolic
degradation of 6-MP. Azathioprine
does in fact appear to have a higher
therapeutic index when compared
to 6-MP in mice, but this has not
yet been established in man.
6-Mercaptopurine has two major
immunological properties that can
be demonstrated in experimental
animals. The first of these is suppression of humoral antibody synthesis. Animals given only a oneweek course of 6-MP fail to
elaborate a normal primary immune response. The second major
effect of this material is on transplantation immunity; a significant
prolongation of homograft survival
can be obtained in a variety of animals treated with 6-MP.
One of the fundamental problems in this field , in fact the problem which I believe to be central
to rational and successful immunosuppressive drug therapy, is that
despite the very specific biochemical sites of action of various antimetabolites, the final result in an
organized cell is its death. Regardless how specific the biochemical
effect of an antimetabolite may be,
the end result is disintegration of
the metabolic cycles of the cell.
Therefore, the central question is

whether any specific immunological effects can be obtained by the
use of materials which are really
cell poisons. In my view, it is
worthless to pursue a generalized
destruction of the immune capability of an individual in order to achieve immunosuppression,
whether in the treatment of an immunological disease or in the establishment of a functioning tissue
graft. We would be trading a possible clinical effect for an immunological cripple.
Immunological Effects of
Cytotoxic Drugs
Quite surprisingly, specific immunological effects can in fact be
obtained by cytotoxic drugs. Depending upon the experimental design, it is possible to delete a
specific immunological reactivity
without affecting an immune response to a randomly selected antigen. Such an animal is not an
immunological cripple. It has acquired immunological tolerance of
an antigen used during the period
of chemotherapy. If this can be
obtained in an experimental animal, there is every reason to believe that it can be also achieved
in man.
One other effect of 6-mercaptopurine, and probably of other
agehts, which · is of considerable
importance in attempting to assess
the reason for their clinical effectiveness, is iJJustrated by experiMCV QUARTERLY 3(2): 80-81 , 1967
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ments on suppression of the Arthus
reaction in hyperimmunized rabbits. In these animals the peripheral
expression of immune injury has
been eliminated without an effect
on the synthesis of antibody. Or,
to put it differently, 6-MP has, in
addition to its capacity to suppress
antibody synthesis, a very potent
anti-inflammatory effect. This will
be seen time and again in clinical
material.
Mechanism of Action of
Cytotoxic Drugs
The mechanism of action of
these drugs in patients with diseases presumed to be on an immunological basis is far from clear.
Some of the questions we have
posed include: 1) Does immunosuppression in fact occur in patients treated with these agents?
2) Can selective immunosuppression be achieved in man? 3) Is
there any correlation between the
degree of immunosuppression
achieved with these agents and the
clinical response? In order to gain
some insight into these questions,
the immune responses of a group
of patients treated with either azathioprine or amethopterin were
measured . Keyhole limpet hemocyanin (KLH), a powerful antigen
long used in experimental animals,
but never before applied to the
study of human immunity, was
used to evaluate the primary response. In normal subjects it provokes both a circulating antibody
response and classical delayed hypersensitivity. Diphtheria toxoid
was used to study the secondary
response. In about a third of the
patients, both primary and secondary immune responses were
completely ablated during chemotherapy. In another third of the
patients the primary immune response was completely suppressed,
but a relatively normal secondary
immune response occurred. Another third of the patients had a
most interesting type of immune
response while on continuous or

even intermittent drug therapy.
This can be called the "accordion"
effect. When compared to the normal immune response, the induction period is greatly prolonged.
However, once antibody synthesis
occurs, there is a very rapid burst
of antibody formation. This occurs
even while the patient is on continuous immunosuppressive drug
treatment.
One of the interesting observations that came out of this study
was the effect of these drugs on
two classes of immunoglobulins,
IgM and JgG. In two-thirds of the
patients on immunosuppressive
drug therapy a greatly prolonged,
but quantitatively normal IgM response occurred in the absence of
any detectable lgG antibody synthesis. Thus, an apparently selective suppression of one molecular
class of antibody may be obtained
with both azathioprine and methotrexate in man.

Clinical Results
The question whether continuous
immunosuppression is required to
maintain a clinical remission in patients with immunological diseases
probably has a negative answer in
light of the "accordion" effect mentioned previously. This is another
reason for believing that treatment
with the currently available immunosuppressive drugs need be
pushed to the point of destruction
of all immune capabilities of the
patient.
The third question, is there any
correlation between the degree of
immunosuppression and the actual
clinical result, is extremely difficult
to answer. In many patients there
is no such correlation. Extensive
depression of immunity does not
indicate that a patient will respond
clinically. Furthermore, some patients with a minimum or no immunosuppression h ave dramatic improvements. We believe that many
of the effects of antimetabolites
we have seen in man. may be
due to their important, but poorly

understood, anti-inflammatory actions.
Conclusion
In conclusion, the antimetabolites have proven extremely interesting in the laboratory for the
exploration of the mechanism of
antibody synthesis and related
problems. They have also proven
to be extremely useful and interesting materials in the clinic.
Whether they are going to replace
any other standard forms of therapy, such as the corticosteroids, is,
in my view, doubtful. Their use at
the moment is experimental and
their ultimate place in clinical medicine is by no means settled. They
appear to have two important
effects in man: 1) Suppression of
antibody formation which can be,
in many individuals, selective; and
2) Very important anti-inflammatory properties which may account
for their effects on immune injury
and for some of the very rapid responses seen in individuals treated
with these agents.
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